AP1G1 Knockout Jurkat Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population designed for targeted disruption of the AP1G1 gene in a human T-lymphocyte background. This product derives from the Jurkat host cell line and offers a heterogeneous pool of cells carrying diverse loss-of-function mutations, enabling robust functional studies without the constraints of clonal selection. The pooled format preserves biological variance while providing a reliable model for investigating AP1G1-dependent processes. As a gene-edited reagent, it serves as a versatile tool for dissecting adaptor protein functions in immune cell biology.
The Jurkat cell line is an immortalized human T-cell line originally established from an acute T-cell leukemia patient. It is a widely adopted model system for examining T-cell signaling, apoptosis, and leukemogenesis. Jurkat cells exhibit key features of T lymphocytes, including surface receptor expression and signal transduction capacity, making them suitable for mechanistic studies of immune responses. Their transformed phenotype also allows for investigation of oncogenic pathways and therapeutic intervention strategies.
AP1G1 encodes the gamma-1 subunit of the adaptor protein complex 1 (AP-1), a clathrin adaptor critical for vesicular trafficking between the trans-Golgi network and endosomes. AP-1 functions by forming clathrin-coated vesicles that sort transmembrane cargo proteins to lysosomes and the plasma membrane. Its activity is regulated by upstream factors such as ADP-ribosylation factor 1 (ARF1), phosphatidylinositol 4-kinase, casein kinase 2 (CSNK2), and cyclin-dependent kinase 5 (CDK5). Key downstream targets include the mannose 6-phosphate receptor (M6PR), lysosomal-associated membrane protein 1 (LAMP1), and MHC class I molecules. AP1G1 directly interacts with clathrin heavy chain, AP1B1 (beta1 subunit), AP1M1 (mu1 subunit), AP1S1 (sigma1 subunit), and ARF1, assembling a functional coat complex that orchestrates cargo selection and budding.
In Jurkat T cells, AP1G1 is essential for polarized secretion and immune synapse assembly, processes that rely on precise spatial and temporal control of vesicular transport. Disruption of AP1G1 leads to impaired sorting of immunoregulatory proteins, altered cell surface receptor composition, and defective T-cell activation. This polyclonal knockout model thus provides a physiologically relevant system to dissect the role of AP-1 in immune cell function, including its contributions to signaling dynamics and intercellular communication. The model is also pertinent to studying AP1G1-related neurodevelopmental disorder and immune dysregulation, as well as acute T-cell leukemia, where aberrant trafficking may contribute to disease pathogenesis.
Researchers can employ this product for a range of applications, including detailed analysis of clathrin-mediated endocytosis and post-Golgi transport steps in T lymphocytes. It supports functional interrogation of AP1G1 mutations, drug screening assays aimed at modulating protein sorting, and mechanistic studies of cargo receptor trafficking. Typical experimental readouts include Western blotting to assess AP1G1 and cargo protein levels, immunofluorescence for subcellular localization of organelle markers, co-immunoprecipitation to probe AP-1 complex assembly, flow cytometry to quantify surface receptor expression, live-cell imaging to monitor vesicle dynamics, and T-cell activation assays to evaluate immune synapse formation. For further details or custom configurations, please contact Ascent Research.
